
    
      The total study duration for one patient is approximately 6.7 to 22.7 weeks (minimum to
      maximum duration, excluding screening). The duration of the study includes a screening period
      of 3 to 28 days (D -28 to D -3), 6 treatment periods of 1 or 2 days each (1 overnight stay),
      a washout period of 7 to 28 days (preferentially 7 days between consecutive dosing), and an
      end-of-study visit of 7 to 14 days after the last study drug administration.
    
  